RSS   Newsletter   Contact   Advertise with us

AMAG Pharmaceuticals appoints Aaron Pelta VP, business development

Share on Twitter Share on LinkedIn
Staff writer | Waltham, Mass., USA | June 11, 2015
Aaron PeltaJune 11, 2015, Waltham, Mass., USA - AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, announced the appointment of Aaron Pelta as vice president of business development and transactions.
Mr. Pelta comes to AMAG with more than 15 years of experience in corporate and business development, commercialization, strategy and operations, having executed multiple mergers, acquisitions and licensing deals.

Prior to joining AMAG, Mr. Pelta served in various positions of increasing responsibility in the business development and commercial groups at Cubist Pharmaceuticals from 2004 to 2015, including senior director, business development, where he led the transaction teams responsible for the acquisitions of Optimer Pharmaceuticals and Adolor Pharmaceuticals.

Most recently, Mr. Pelta served as the brand lead for DIFICID, where he led the commercial re-launch of the product.

Prior to Cubist, he worked in the commercial analytics group at Biogen, where he supported the sales and marketing teams in launching Amevive. He also served in research & development and engineering roles at Gamera Bioscience and Praxair, Inc.

Mr. Pelta holds a bachelor's of science in chemical engineering from Tufts University and a master's of business administration from the Tuck School of Business at Dartmouth College.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST